| 2B4 utilizes ITAM-containing receptor complexes to initiate intracellular signaling and cytolysis AT Bida, JLU Neff, CJ Dick, RA Schoon, A Brickshawana, CC Chini, ... Molecular immunology 48 (9-10), 1149-1159, 2011 | 25 | 2011 |
| 406 Invasive Migration of Pancreatic Tumor Cells is Potentiated by a Novel Stabilization of the Oncogenic RAC GEF Vav1 by the Large GTPase Dynamin 2 GL Razidlo, Y Wang, J Chen, DD Billadeau, MA McNiven Gastroenterology 5 (142), S-90, 2012 | | 2012 |
| 519 WASH complex conservation: don’t WASH away the family! 520 Response to letter by Insall DD Billadeau, MNJ Seaman, A Gautreau, J Mine-Hattab, R Rothstein, ... | | |
| 72 Glycogen Synthase Kinase-3β (GSK-3β) Inhibition Attenuates Hepatocyte Lipoapoptosis SH Ibrahim, Y Akazawa, S Cazanave, SF Bronk, N Elmi, DD Billadeau, ... Gastroenterology 5 (138), S-774, 2010 | | 2010 |
| A balance between positive and negative signals in cytotoxic lymphocytes regulates the polarization of lipid rafts during the development of cell-mediated killing Z Lou, D Jevremovic, DD Billadeau, PJ Leibson The Journal of experimental medicine 191 (2), 347-354, 2000 | 163 | 2000 |
| A combination of IL-10 and direct contact with plasma cell tumors decreases CD23 expression on splenic B cells. MC Ruzek, D Billadeau, A Mathur Journal of immunology (Baltimore, Md.: 1950) 156 (6), 2124-2132, 1996 | 4 | 1996 |
| A CVID-associated variant in the ciliogenesis protein CCDC28B disrupts immune synapse assembly N Capitani, A Onnis, F Finetti, C Cassioli, A Plebani, J Brunetti, A Troilo, ... Cell Death & Differentiation 29 (1), 65-81, 2022 | 7 | 2022 |
| A Dyn2–CIN85 complex mediates degradative traffic of the EGFR by regulation of late endosomal budding B Schroeder, SG Weller, J Chen, D Billadeau, MA McNiven The EMBO Journal 29 (18), 3039-3053, 2010 | 55 | 2010 |
| A FAM21-containing WASH complex regulates retromer-dependent sorting TS Gomez, DD Billadeau Developmental cell 17 (5), 699-711, 2009 | 527 | 2009 |
| A new synthetic lethal strategy expands the application of PARP inhibitors/cisplatin J Wang, DD Billadeau, Y Zheng, D Jia MedComm–Oncology 2 (2), e28, 2023 | | 2023 |
| A NOVEL VAV1-GLI1 AXIS CONNECTS THE HEDGEHOG AND EGF PATHWAY IN PANCREATIC CANCER A Comba, LJ Peña-Sanchez, JJ Han, ME Pasqualini, DD Billadeau, ... Pancreas 37 (4), 465-466, 2008 | | 2008 |
| A phosphoinositide cascade regulates a receptor recycling pathway LS Weisman, S Srinivas Panapakkam Giridharan, G Luo, P Rivero‐Rios, ... The FASEB Journal 36, 2022 | | 2022 |
| A regulatory role of the endosomal sorting machinery in controlling plasma LDL cholesterol levels and atherosclerosis in mice and humans JD Billadeau, J Horton, E Burstein, A Tybjaerg-Hansen, JA Kuivenhoven, ... Abstracts/Atherosclerosis Supplements 32 (1e162), 18, 2018 | 1 | 2018 |
| A role for a RhoA/ROCK/LIM-kinase pathway in the regulation of cytotoxic lymphocytes Z Lou, DD Billadeau, DN Savoy, RA Schoon, PJ Leibson The Journal of Immunology 167 (10), 5749-5757, 2001 | 64 | 2001 |
| A Series of Potent and Selective, Triazolylphenyl-Based Histone Deacetylases Inhibitors with Activity against Pancreatic Cancer Cells and Plasmodium falciparum Y Chen, M Lopez-Sanchez, DN Savoy, DD Billadeau, GS Dow, ... Journal of medicinal chemistry 51 (12), 3437-3448, 2008 | 151 | 2008 |
| Aberrant nuclear accumulation of glycogen synthase kinase-3β in human pancreatic cancer: association with kinase activity and tumor dedifferentiation AV Ougolkov, ME Fernandez-Zapico, VN Bilim, TC Smyrk, ST Chari, ... Clinical cancer research 12 (17), 5074-5081, 2006 | 186 | 2006 |
| Abstract B09: GSK-3β blockade with 9-ING-41 in pancreas cancer: The 1801 phase 1/2 study BA Carneiro, M Dhawan, B Borden, L Cavalcante, H Safran, A Ugolkov, ... Cancer Research 79 (24_Supplement), B09-B09, 2019 | | 2019 |
| Abstract CT222: Multimodal mechanism of action of the GSK-3 inhibitor 9-ING-41 (elraglusib) includes an immunomodulatory component: preliminary results from the 1801 phase 1/2 … T Weiskittel, J McDermott, D Billadeau, H Li, A Saeed, D Mahalingam, ... Cancer Research 83 (8_Supplement), CT222-CT222, 2023 | | 2023 |
| Acridine-based agents with topoisomerase II activity inhibit pancreatic cancer cell proliferation and induce apoptosis JR Goodell, AV Ougolkov, H Hiasa, H Kaur, R Remmel, DD Billadeau, ... Journal of medicinal chemistry 51 (2), 179-182, 2008 | 131 | 2008 |
| Actin cytoskeleton vulnerability to disulfide stress mediates disulfidptosis X Liu, L Nie, Y Zhang, Y Yan, C Wang, M Colic, K Olszewski, A Horbath, ... Nature cell biology 25 (3), 404-414, 2023 | 389 | 2023 |